NEU 2.37% $19.39 neuren pharmaceuticals limited

Ann: Neuren commences Phase 2 trial of NNZ-2591 in Angelman, page-19

  1. 268 Posts.
    lightbulb Created with Sketch. 91
    This Phase 2 trial opened for recruitment 12th July 2022 ..... almost exactly a year ago.
    The USA website referred to in this presentation indicates 20 participants needed and completion expected last May.
    Googling gives the info that in Australia there are approx 500 known individuals and probably another 1,000 yet to be diagnosed
    .... so with 500 potential participants why is this trial taking so long? Does anyone here know?
    .

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.